Genetic Polymorphisms Contribute to Acute Kidney Injury after Coronary Artery Bypass Grafting

Authors

  • Selim C. Isbir
  • Atike Tekeli
  • Arzu Ergen
  • Hulya Yilmaz
  • Koray Ak
  • Ali Civelek
  • Umit Zeybek
  • Sinan Arsan

DOI:

https://doi.org/10.1532/HSF98.20071117

Abstract

Background. Acute kidney injury is one of the most serious complications after cardiac surgery. Genetic polymorphisms are reported to be associated with postoperative renal impairment. The aim of this study was to investigate the relationship between selected gene polymorphisms and acute kidney injury after cardiac surgery.

Methods. Two hundred forty-eight elective coronary artery bypass grafting procedure patients were enrolled in the study. Angiotensin-converting enzyme (ACE) II, ID, and DD, apolipoprotein E (APO E), and angiotensin II type 1 receptor (AGTR1) A1166C genotypes were detected by polymerase chain reaction. Plasma levels of ACE were analyzed by enzyme-linked immunosorbent assay. Acute kidney injury after cardiac surgery was graded according to the RIFLE (risk, injury, failure, loss, and end-stage kidney disease) classification.

Results. In our study, 21.8% of patients had acute renal impairment after cardiac surgery. Among the 54 patients with acute kidney injury, ACE D allele frequency was 0.620. The plasma levels of ACE were significantly higher in the D allele carriers (P = .018). Three of the 54 patients with acute kidney injury were APO E ?4 allele carriers (P = .002). AGTR1 C allele carriers constituted 46% of all patients with postoperative acute kidney injury. There was no statistically significant difference between A allele homozygotes and C allele carriers with respect to postoperative renal dysfunction (P > .05).

Conclusions. The present findings support the hypothesis that ACE I/D and APO E gene polymorphisms may play a role in the development of acute kidney injury after cardiac surgery. However, AGTR1 does not have a unique association with postoperative renal impairment.

References

Bautista LE, Ardila ME, Gamarra G, et al. 2004. Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med Sci Monit 10:473-9.nBell M, Liljestam E, Granath F, et al. 2005. Optimal follow-up after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 20:354-60.nBellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup. 2004. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204-12.nBenetos A, Gautier S, Ricard S, et al. 1996. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 94:698-703.nChew ST, Newman MF, White WD, et al. 2000. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93:325-31.nDanser AH, Schalekamp MA, Bax WA, et al. 1995. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-8.nHeringlake M, Knappe M, Vargas Hein O, et al. 2006. Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol 72:645-54.nIlhan N, Seckin D, Ilhan N, et al. 2005. Association of angiotensinconverting enzyme and angiotensinogen T174M gene polymorphisms with coronary artery disease. Adv Mol Med 1:181-8.nKontula K, Aalto-Setala K, Kuusi T, et al. 1990. Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping isoelectric focusing. Clin Chem 36:2087-92.nKuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. 2006. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 81:542-6.nLassnigg A, Schmidlin D, Mouhieddine M, et al. 2005. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 16:195-200.nLeatham E, Barley J, Redwood S, et al. 1994. Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 8:635-8.nLosito A, Selvi A, Jeffery S, et al. 2000. Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension. Am J Hypertens 13:128-33.nMacKensen GB, Swaminathan M, Ti LK, et al; Perioperative Outcomes Research Group; Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.) Investigators of the Duke Heart Center. 2004. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg 78:520-6.nMiller SA, Dykes DD, Polesky HF. 1988. Simples salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215.nNakai K, Itoh C, Miura Y, et al. 1994. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90:2199-2202.nRaynolds MV, Bristow MR, Bush EW, et al. 1993. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-5.nRigat B, Hubert C, Corvol P, Soubrier F. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucl Acids Res 20:1433.nSayed-Tabatabaei FA, Schut AF, Vasquez AA, et al. 2005. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam study. J Med Genet 42:26-30.nSchut AF, Bleumink GS, Stricker BH, et al. 2004. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 25:2143-8.nShanmugam V, Sell KW, Saha BK. 1993. Mistyping of ACE heterozygotes. PCR Methods Appl 3:120-1.nStafford-Smith M, Podgoreanu M, Swaminathan M, et al; Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team. 2005. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 45:519-30.nTiret L, Bonnardeaux A, Poirier O, et al. 1994. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-3.nTokgozoglu SL, Alikasifoglu M, Atalar E, et al. 1997. ACE gene polymorphism and risk and extent of ischemic heart disease among Turkish patients. Coronary Artery Dis 8:137-41.nVolzke H, Engel J, Kleine V, et al. 2002. Angiotensin I- converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest 122:31-6.n

Published

2007-10-05

How to Cite

Isbir, S. C., Tekeli, A., Ergen, A., Yilmaz, H., Ak, K., Civelek, A., Zeybek, U., & Arsan, S. (2007). Genetic Polymorphisms Contribute to Acute Kidney Injury after Coronary Artery Bypass Grafting. The Heart Surgery Forum, 10(6), E439-E444. https://doi.org/10.1532/HSF98.20071117

Issue

Section

Articles

Most read articles by the same author(s)